Xenon Pharmaceuticals (XENE) Earnings Date & Reports

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

XENE is expected to report earnings to rise 9.70% to -92 cents per share on May 13

Xenon Pharmaceuticals XENE Stock Earnings Reports

Q1'25

Est.

$-0.92

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.01

Q2'24

Missed

by $0.05

Q1'24

Beat

by $0.04

The last earnings report on February 27 showed earnings per share of -83 cents, beating the estimate of -85 cents. With 904.03K shares outstanding, the current market capitalization sits at 2.35B.

View a ticker or compare two or three

Compare

XENE